Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Birth control pills can help reduce mild to moderate acne in women.

Oral contraceptives may cause hair loss in women.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

Iraqi women with PCOS often have higher testosterone levels and obesity.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.